Avenue Therapeutics Inc. (ATXI)
NASDAQ: ATXI
· Real-Time Price · USD
0.50
-0.04 (-7.41%)
At close: Aug 11, 2025, 11:48 AM
Avenue Therapeutics Ratios and Metrics
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
PE Ratio | -0.12 | -0.52 | -0.32 | -0.13 | -0.36 | 120.69 | 204.51 | -42.47 | -16.13 | 53.18 | -418.54 | -183.21 | -66.13 | -340.41 | -533.09 | -821.24 | -1.89K |
PEG Ratio | 0.00 | 0.00 | 0.00 | 0.01 | 0.00 | -1.21 | -1.82 | 0.69 | 0.01 | -0.06 | -42.9 | 1.84 | -0.00 | 67.23 | 65.49 | 184.78 | n/a |
PS Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PB Ratio | 0.25 | 1.14 | 1.53 | 0.80 | 2.23 | 195.30 | -117.89 | -127.58 | -334.9 | 31.32 | -28.42K | 740.17 | 652.93 | 360.23 | -11.61K | 4.86K | 5.11K |
P/FCF Ratio | -0.75 | -4.19 | -1.38 | -1.69 | -2.03 | 457.05 | -227.78 | -102.14 | -309.14 | -29.34 | -2K | -469.38 | -392.09 | -1.03K | -3.47K | -4.43K | -5.77K |
P/OCF Ratio | -0.75 | -4.19 | -1.38 | -1.69 | -2.03 | -132.95 | -484.01 | -145.93 | -309.14 | -29.34 | -2K | -469.38 | -392.09 | -1.03K | -3.47K | -4.43K | -5.77K |
OCF/S Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Quick Ratio | 2.85 | 3.27 | 2.70 | 4.30 | 2.34 | 1.55 | 0.04 | 0.21 | 0.80 | 1.91 | 0.94 | 2.47 | 2.45 | 7.96 | 0.81 | 2.17 | 4.14 |
Current Ratio | 2.85 | 3.27 | 2.70 | 4.30 | 2.34 | 1.55 | 0.10 | 0.21 | 0.80 | 1.91 | 0.94 | 2.47 | 2.45 | 7.78 | 0.81 | 2.17 | 4.14 |
Asset Turnover | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Interest Coverage | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -19.36 | -3.37 | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Return on Equity | -0.53 | -0.55 | -1.18 | -1.51 | -1.53 | 0.40 | -0.14 | 0.75 | 5.19 | 0.15 | 16.97 | -1.01 | -2.47 | -0.26 | 5.44 | -1.48 | -0.68 |
Return on Assets | -0.52 | -0.58 | -1.17 | -1.44 | -1.31 | 0.35 | 1.05 | -2.41 | -0.89 | 0.08 | -1.15 | -0.6 | -1.46 | -0.23 | -1.27 | -0.8 | -0.51 |
Return on Invested Capital | -0.82 | -0.82 | -1.91 | -0.74 | -1.96 | -2.94 | 0.49 | 0.64 | 2.98 | -1.15 | -2.21 | -1.01 | -2.47 | -0.26 | 5.45 | -1.48 | -0.68 |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Net Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |